ACM
SPRB

AIGH Capital Management’s Spruce Biosciences SPRB Stock Holding History

AIGH Capital Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Buy
+250,000
New +$14M 0.85% 21
2024
Q1 		– Sell
-28,318
Closed -$6.22M – 52
2023
Q4 		$6.22M Buy
28,318
+12,171
+75% +$1.41M 2.46% 13
2023
Q3 		$2.74M Buy
16,147
+1,334
+9% +$225K 1.3% 23
2023
Q2 		$2.39M Buy
14,813
+93
+0.6% +$15.5K 0.97% 26
2023
Q1 		$2.37M Buy
+14,720
New +$2.73M 0.87% 28

Other funds holding SPRB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

AIGH Capital Management's SPRB Position: Q2 2026 in Review

AIGH Capital Management opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 250,000 shares worth $13.5M. The stake represents 0.85% of the portfolio and ranks #21 among its holdings. This is a return to the name: AIGH Capital Management previously reported a position in SPRB as recently as Q4 2023.

AIGH Capital Management first reported a position in SPRB in Q1 2023 and has held it in 5 quarters since. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • AIGH Capital Management held 250,000 shares of Spruce Biosciences worth $13.5M as of Q2 2026.
  • Spruce Biosciences was a new AIGH Capital Management position in Q2 2026.
  • Spruce Biosciences made up 0.85% of AIGH Capital Management's portfolio in Q2 2026, its #21 holding.
  • AIGH Capital Management first reported a position in Spruce Biosciences in Q1 2023 and has held it in 5 quarters since.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.